Monthly Newsletter from the Arizona Asthma Coalition |
|
|
AstraZeneca Sets $35 Monthly Cap on Inhaler Costs
RT Magazine
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines. Expanding the savings programs will help make its inhalers more affordable to the most vulnerable patients living with asthma and chronic obstructive pulmonary disease (COPD), including those who are uninsured and underinsured, according to a release from the company.
|
|
|
|
|
New asthma cause identified – and a new angle for treatment
New Atlas
As common as asthma is, exactly how it starts remains murky. Scientists have now identified a new root cause, and importantly a new angle for treating the disease that can prevent the main symptoms. |
|
|
|
|
Discovery of how limiting damage from an asthma attack could stop disease
Science Daily/King's College London
Scientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease.
Most current asthma treatments stem from the idea that it is an inflammatory disease. Yet, the life-threatening feature of asthma is the attack or the constriction of airways, making breathing difficult. The new study, published today in Science, shows for the first time that many features of an asthma attack -- inflammation, mucus secretion, and damage to the airway barrier that prevents infections -- result from this mechanical constriction in a mouse model. |
|
|
|
|
Why Do Some People Experience Asthma Symptoms Despite Treatment?
Yale School of Medicine - Yale University
While there is no cure for asthma, many people successfully manage the condition. Others experience asthma symptoms, such as shortness of breath, despite taking medication. A new study offers insight into why some groups of patients with asthma may not respond to treatment.
In the study, published in the Journal of Allergy and Clinical Immunology, researchers focused on eosinophils, a type of cell associated with lung function and asthma. For more than a decade, as the recognition of the role of eosinophils in asthma has grown, multiple eosinophil-directed treatments, including mepolizumab, have been developed. |
|
|
|
|
IngMar Medical Launches Aurora Simulation Manikin
RT Magazine
IngMar Medical has released Aurora, a medical simulation manikin used to train clinicians in all forms of ventilation, according to a company news release. Aurora’s new Internal Simulated Lung (ISL) is based on the IngMar’s ASL 5000 Breathing Simulator technology.
The technology elevates medical training by offering a tetherless, internal system which interacts realistically with all forms of ventilation including bag-valve mask, noninvasive, and invasive ventilation. |
|
|
|
|
LUNG FORCE Walk - Tucson
Saturday, May 4
The LUNG FORCE Walk is coming back to Tucson! Join us and turn small steps into bold strides toward a world without lung cancer and lung disease.
Come out and experience the celebratory and welcoming atmosphere of a LUNG FORCE event.
It doesn't matter how you roll, whether you like to saunter, power-walk or stroll. There's a Walk Your Way virtual option for those who can't make it to the event.
The LUNG FORCE Walk provides critical funds for lifesaving research, early detection initiatives, and awareness outreach to vulnerable communities.Register today and save your spot. |
|
|
|
|
FDA-approved Anti-inflammatory Rescue Inhaler for Asthma Now Available
RT Magazine
AstraZeneca announces Airsupra (albuterol/budesonide) for adults with asthma is now commercially available in the United States by prescription. Airsupra received US Food and Drug Administration (FDA) approval in January 2023 for the as-needed treatment or prevention of symptoms of asthma and to help prevent sudden severe breathing problems (asthma attacks) in people aged 18 years and older. |
|
|
|
|
Join the Arizona Asthma Coalition As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work. Join or renew here |
|
|
|
